Understand WHO GMP certification, its importance in pharmaceutical exports, and what buyers should verify before choosing a manufacturing partner.
Explore what US buyers should check when choosing pharmaceutical contract manufacturers in India for reliable and compliant US market supply.
See how global pharma buyers pick Indian contract manufacturers for export, and how Caritas Healthcare supports reliable, compliant production.
A practical guide for international buyers on selecting a reliable pharma manufacturing partner in India, backed by Caritas Healthcare's export expertise.
In the pharmaceutical industry, a delayed delivery is not a logistical inconvenience; it is a threat to patient health and healthcare system reliability. For over a decade, Caritas Healthcare has built its reputation on a single, non-negotiable promise: consistent, on-time pharmaceutical delivery across 30+ countries.
The pharmaceutical distribution landscape is evolving rapidly. According to Grand View Research, the global pharmaceutical distribution market is projected to reach $1.3 trillion by 2030, driven by expanding healthcare access and rising demand for quality medicines across emerging markets. For entrepreneurs and established distributors alike, aligning with a branded generics pharmaceutical company offers significant pharma business opportunities, but only when the partnership model is designed for mutual growth.
Emerging markets are reshaping the global pharmaceutical landscape. According to IQVIA, emerging markets are projected to account for over 30% of global pharmaceutical spending by 2026, with growth rates consistently outpacing developed markets.
In the pharmaceutical industry, compliance is not merely a regulatory checkbox; it is the bedrock of patient safety, market access, and international credibility. According to the World Health Organization, substandard and falsified medical products cause an estimated 267,000 deaths annually in low- and middle-income countries alone.